Luke Ward
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 1
- Genetics 6
- Genetic Associations and Epidemiology 6
- Journals
- JAMA (7 papers)Nature (4 papers)Human Genetics and Genomics Advances (1 paper)Institutional Repositories DataBase (IRDB) (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Luke Ward
11 papers receiving 1.5k citations
Luke Ward's Hit Papers
Peers
Comparison fields: 5 of 86
- Infectious Diseases 801
- Genetics 504
- Neurology 87
- Internal Medicine 18
- Immunology 102
Countries citing papers authored by Luke Ward
This map shows the geographic impact of Luke Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Ward more than expected).
Fields of papers citing papers by Luke Ward
This network shows the impact of papers produced by Luke Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Ward. The network helps show where Luke Ward may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | 2021 | 166 | |
| 4 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 5 | 2022 | 105 | |
| 6 | 2022 | 100 | |
| 7 | 2023 | 60 | |
| 8 | 2023 | 46 | |
| 9 | 2024 | 45 | |
| 10 | 2023 | 34 | |
| 11 | 2024 | 8 | |
| 12 | 2021 | 0 | |
| 13 | 2026 | 0 |
About Luke Ward
Luke Ward is a scholar working on Infectious Diseases, Genetics, Critical Care and Intensive Care Medicine, Nutrition and Dietetics and Epidemiology, having authored 13 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Genetic Associations and Epidemiology (6 papers), Intensive Care Unit Cognitive Disorders (1 paper), Vitamin C and Antioxidants Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (801 citations), Genetics (504 citations), Neurology (87 citations), Internal Medicine (18 citations) and Immunology (102 citations). Luke Ward has collaborated with scholars based in United Kingdom. Their work appears in journals such as JAMA, Nature, Human Genetics and Genomics Advances and Institutional Repositories DataBase (IRDB).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.